小儿推拿治疗孤独症谱系障碍儿童:随机对照试验研究方案
本研究为随机对照试验方案,拟将符合条件的孤独症谱系障碍(ASD)儿童按1:1随机分为小儿推拿加常规治疗组与单纯常规治疗组,由第三方机构评估疗效。主要结局为儿童孤独症评定量表干预前后评分,次要结局为孤独症治疗评估量表干预前后评分,于第30次治疗结束后评估,随访6个月。
要点
- 小儿推拿加常规治疗与单纯常规治疗按1:1随机分组比较疗效。
- 主要结局为儿童孤独症评定量表干预前后评分。
- 次要结局为孤独症治疗评估量表干预前后评分,第30次治疗结束后评估。
核心结论
- 本研究将评估推拿治疗ASD的有效性和安全性,结果可能为改善ASD患者管理提供可靠证据。
研究设计与样本
- 随机对照试验方案,符合条件的儿童按随机数字表以1:1比例随机分配至小儿推拿加常规治疗组或单纯常规治疗组。
- 由第三方机构评估推拿干预ASD的有效性,基线值在入组时确定。
主要发现
- 主要结局为儿童孤独症评定量表干预前后评分。
- 次要结局为孤独症治疗评估量表干预前后评分,以评估症状改善。
- 结局在第30次治疗结束后评估,治疗后随访6个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by repetitive stereotypical behavior and communication deficits. Currently, it lacks a specific clinical treatment method. Pediatric Tuina is a recent therapy in traditional Chinese medicine (TCM) and has been used to treat children with ASD. Nonetheless, it remains uncommon given the lack of large-scale evidence-based medical studies. This study aims to compare the efficacy of Tuina and conventional treatment in children with ASD. METHODS: Eligible children will be randomly assigned to either the pediatric Tuina plus conventional treatment group or to the conventional treatment alone group based on a random table at a ratio of 1:1. The effectiveness of the Tuina intervention for ASD will be evaluated by a third-party organization. The pre- and post-intervention scores on the Childhood Autism Rating Scale comprised the primary outcome, whereas pre- and post-intervention scores on the Autism Treatment Evaluation Checklist were the secondary outcomes to assess improvement in symptoms. Baseline values of the participants will be determined at the time of registration. Outcomes will be evaluated after the 30th treatment session. The follow-up period will last for 6 months after treatment. DISCUSSION: This study will evaluate the effectiveness and safety of Tuina in the treatment of ASD. The results of this study could provide reliable evidence to improve the management of patients with ASD. TRIAL REGISTRATION: Chinese Clinical Trial Registry (CHICTR), ChiCTR2000040452 . Registered on 28 November 2020.
引用
- Feng X, Jiang Q, Zhang Y, et al. Pediatric Tuina in children with autism spectrum disorder: a study protocol for a randomized controlled trial. Trials. 2022. PMID: 35078520. doi:10.1186/s13063-022-06030-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。